Lawrence F. Eichenfield, MD - Rady Children's Hospital

More documents

Recommendations

Info

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.13. Cotton swab technique for obtaining cultures in patients with suspected tinea capitis. EighthInternational Congress Pediatric Dermatology, Paris, France. Ann Dermatology1998;125(S1):53. May, 1998 (Abstract).14. Topically applied tacrolimus ointment vs. vehicle ointment in pediatric patients with atopicdermatitis. American Academy of Dermatology Annual Meeting. March, 2000 (Poster).15. Complications of general anesthesia in pediatric patients undergoing dermatologic surgicalprocedures. American Society for Dermatologic Surgery. Denver, CO. November 5, 2000(Abstract).16. Low blood concentrations of SDZ ASM 981 in infants with extensive atopic dermatitis treatedwith cream 1%. American Academy of Dermatology Annual Meeting. March, 2001 (Poster).17. Safety, pharmacokinetics, tolerability and efficacy of topical SDZ ASM 981. InternationalSymposium on Atopic Dermatitis. September, 2001 (Abstract).18. Effect of a single course of accutane® therapy on bone mineral density (BMD) in pediatricpatients with severe, recalcitrant, nodular acne (Poster).19. Use of Protopic ointment in atopic dermatitis patients with limited disease. American Academyof Dermatology Annual Meeting. New Orleans, LA. February, 2002 (Abstract and Poster).20. Pimecrolimus (SDZ ASM 981) cream is safe in the long-term control of atopic dermatitis.American Academy of Dermatology Summer Meeting. July 29, 2001 (Abstract).21. Potential role of pimecrolimus as maintenance therapy for atopic dermatitis. Eichenfield LF,Leung D. American Academy of Allergy, Asthma and Immunology Annual Meeting. NewYork, NY. March 1-3, 2002 (Poster).22. Low blood concentrations of SDZ ASM 981 in infants treated with cream 1%. Wahn U, PariserD, Gottlieb AB, Kaufmann R, Eichenfield LF, Langely R, Bueche M, Barilla D, Ebelin ME.International Symposium on Atopic Dermatitis. Portland, OR. September 6-9, 2001 (Abstract).23. Safety, pharmacokinetics, tolerability, and efficacy of topical SDZ ASM 981 (pimecrolimus)and FK 506 (tacrolimus) in pediatric atopic dermatitis: a comparison of clinical studies.Eichenfield LF, Bernard LB. International Symposium of Atopic Dermatitis. Portland, OR.September 6-9, 2001 (Abstract).24. Gluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even inpeanut-sensitive patients. Dohil M, Paller AS, Nimmagadda S, Eichenfield LF. Ann DermatolVenereol 2002; 129:1S211-1S285 (Abstract).25. Pimecrolimus (SDZ ASM 981) cream 1% is safe in the long-term management of atopiceczema. Boguniewicz M, Eichenfield LF, Honig P, Langley R, Lucky A, Paller A, Marshall K,Bush C, Cherill R, Graeber M. The 10th Congress of European Academy of Dermatology andVenereology (EADV). Munich, Germany. October 10-14, 2001 (Abstract and Poster).26. Port-wine stain: neonatal management. Eichenfield LF. Ann Dermatol Venereol 2002;129:1S211-1S285 (Abstract).27. Elidel® in clinical practice: 9-months experience in the USA. Eichenfield LF. EuropeanAcademy of Dermatology and Venereology JEADV 2002; 97:15(Suppl1) (Abstract).Page 32 of 69
Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.28. Pediatric dermatology in the USA. Eichenfield LF. Dermatology from young to old. June 12-15, 2003. Rotterdam (Abstract).29. Classification of vascular abnormalities. Eichenfield LF. Dermatology from Young to Old. June12-15, 2003. Rotterdam (Abstract).30. Topical Corticosteroids. Eichenfield LF. Dermatology from young to old. June 12-15, 2003.Rotterdam (Abstract).31. Molluscum contagiosum in children – who gets them? Dohil M, Paller A, Lucky A, Lee J,Eichenfield LF. Society for Pediatric Dermatology 29th Annual Meeting. June 18-21, 2003(Poster).32. Successful treatment of intractable pruritus with transcutaneous electrical nerve stimulation(TENS) in children with atopic dermatitis. Shainhouse T, Bergman J, Cunningham B,Friedlander SF, Eichenfield LF. Society for Pediatric Dermatology 29th Annual Meeting. June18-21, 2003 (Poster).33. Pimecrolimus (SDZ ASM 981) blood levels are consistently low in children with extensiveatopic eczema. Harper J, Lakhanpaul M, Wahn U, Pariser D, Gottlieb AB, Kaufmann R,Eichenfield LF, Langley R, Scott G, Ebelin ME, Burtin P. The 10th Congress of the EuropeanAcademy of Dermatology and Venereology (EADV). Munich, Germany. October 10-14, 2001(Abstract and Poster).34. Safety and efficacy of topical tacrolimus ointment (Protopic®) in young children 2 to 6 years ofage with atopic dermatitis. Leung D, Eichenfield LF. American Academy of DermatologyAnnual Meeting. New Orleans, LA. February, 2002.35. Long-term safety of topically applied tacrolimus ointment (Protopic®) in pediatric patients 2-15 years of age with atopic dermatitis. Paller A, Hanifin J, Eichenfield LF, et al. AmericanAcademy of Dermatology Annual Meeting. New Orleans, LA. February, 2002 (Poster).36. Double-blind, randomized, placebo-controlled, multicenter study to assess two strengths oftretinoin microsphere gel (TMG) in the treatment of acne vulgaris. Eichenfield LF, et al.American Academy of Dermatology Annual Meeting. New Orleans, LA. February, 2002(Abstract).37. Double-blind, randomized, vehicle-controlled, multicenter study to assess the safety andefficacy of tretinoin microsphere gel (TMG) 0.04% in the treatment of acne vulgaris. Berger R,Eichenfield LF, et al. American Academy of Dermatology Annual Meeting. New Orleans, LA.February, 2002 (Abstract).38. Use of tacrolimus ointment in atopic dermatitis patients with limited disease. Leung D,Eichenfield LF, Fleischer A, Korman N, Paller A, Rico MJ, Satoi Y, Maher R. AmericanAcademy of Dermatology Annual Meeting. February 22-27, 2002 (Poster).39. Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patientsfrom the pimecrolimus 1% cream clinical programme. Hanifin J, Allen R, De Prost Y, Luger T,Eichenfield LF, et al. Ann Dermatol Venereol 2002; 129:1A371-1S602 (Abstract).40. Pimecrolimus (SDZ ASM 981) cream is effective in patients aged 3 months to 17 years withatopic dermatitis. Lucky A, Ho V, Boguniewicz M, Gupta A, Kaufmann R, Ling M, Todd G,Eichenfield LF, et al. Ann Dermatol Venereol 2002; 129:1S371-1S602 (Abstract).Page 33 of 69
Page 3 and 4: Curriculum VitaeAugust 2012Lawrence
Page 6 and 7: Curriculum VitaeAugust 2012Graduate
Page 12 and 13: Curriculum VitaeAugust 2012Physicia
Page 62 and 63: Curriculum VitaeAugust 2012Sarah Hi
Page 64 and 65: Curriculum VitaeAugust 2012Laurie B

Lawrence F. Eichenfield, MD - Rady Children's Hospital

Create successful ePaper yourself

Delete template?

Save as template?